Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Wednesday, 29 November 2017

Zealand Pharma to attend three U.S. healthcare conferences in December

Zealand Pharma    

Published: 10:37 CET 29-11-2017 /GlobeNewswire /Source: Zealand Pharma / : ZEAL /ISIN: DK0060257814

Zealand Pharma to attend three U.S. healthcare conferences in December

Press release - No. 12 / 2017

Zealand Pharma to attend three U.S. healthcare conferences in December

 

 

Copenhagen, November 29, 2017 - Britt Meelby Jensen, President and Chief Executive Officer (CEO) and Mats Blom, Executive Vice President and Chief Financial Officer (CFO) of Zealand Pharma, will be present at the Carnegie Nordic Healthcare Day, New York, on Tuesday, December 5, 2017 and at the Citi Healthcare Conference, New York, on Wednesday, December 6, 2017.

Mats Blom, Executive Vice President and Chief Financial Officer (CFO) of Zealand Pharma, will be present at the Guggenheim Annual Boston Healthcare Conference, Boston, on Wednesday, December 13, 2017.


For further information, please contact:

Mats Blom, Executive Vice President and Chief Financial Officer

Tel.: +45 31 53 79 73, e-mail: mabl@zealandpharma.com

 

About Zealand Pharma A/S

Zealand Pharma A/S (Nasdaq Copenhagen and New York: ZEAL) ("Zealand") is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. Zealand has a portfolio of medicines and product candidates under license collaborations with Sanofi and Boehringer Ingelheim as well as a pipeline of internal product candidates focusing on specialty gastrointestinal and metabolic diseases.

Zealand is based in Copenhagen (Glostrup), Denmark. For further information about the Company's business and activities, please visit
www.zealandpharma.com or follow Zealand on LinkedIn or Twitter @ZealandPharma.

 



12_17_2911_Carnegie Citi and Guggenheim



This announcement is distributed by Nasdaq Corporate Solutions (One Liberty Plaza, 165 Broadway, New York, NY 10006. Tel: +1 212 401 8700. www.nasdaqomx.com) on behalf of Nasdaq Corporate Solutions clients. Source: Zealand Pharma, Smedeland 36, Glostrup 2600, Danmark
If you would like to unsubscribe and stop receiving these e-mails click here.